The aim of our study is to investigate the etiological distribution of ILD, epidemiological characteristics of ILD cases such as age, gender, geography, smoking, occupation, economic status, education, and comorbidities. Another aim is to make the cost calculation from the first to the diagnosis in the patients diagnosed. Obtaining the missing data related to the ILD of our country is one of our goals.
Study Type
OBSERVATIONAL
Enrollment
1,000
Department Of Chest Diseases, School Of medicine, Karadeniz Technical University
Trabzon, Turkey (Türkiye)
Etiological distribution
The aim of our study is to investigate the etiological distribution of ILD
Time frame: 1 year
Etiological distribution
Geographic distribution of ILD patients according to regions (will be presented as %)
Time frame: 1 year
Epidemiological characteristics of ILD cases
Age (years)
Time frame: 1 year
Epidemiological characteristics of ILD cases
Gender (male, female; (will be presented as %))
Time frame: 1 year
Epidemiological characteristics of ILD cases
Smoking (yes, no; (will be presented as %)
Time frame: 1 year
Epidemiological characteristics of ILD cases
Distribution of ILD patients according to the occupation (will be presented as %)
Time frame: 1 year
Epidemiological characteristics of ILD cases
Economic status (monthly salary of patients according to ILD types and stages of ILD)
Time frame: 1 year
Epidemiological characteristics of ILD cases
Distiribution of ILD patienst according to comorbidities (will be presented as YES or NO and %) Comorbiditites are; Hypertension, Heart failure, Coronary Artery Disease, Arrhythmia, Heart Valve Disease, Asthma, COPD, Chronic Renal Disease, Diabetes Mellitus, Hyper / Hypothyroidism, HIV, Cirrhosis / Chronic Liver Disease, Lung malignancy, Extrapulmonary solid organ malignancy, Hematologic malignancy, SVO, Alzeimer, Epilepsy, Neuromuscular Ill, Organ Transplant Receiver, Reflux, Slyding hernia, Others
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 1 year
Total number
We planned enroll roughly 1000 patients to the study
Time frame: 1 year
Clinical findings
According to the etiology of ILD, clinical findings (Rod, Ral, Rash, Arthritis, Alopecia, Erythema nodosum, Peripheral lymphadenomegaly, Cyanosis, Edema, Raynaud's phenomenon, Other) will be presented as YES or NO and %
Time frame: 1year
Pulmonary functions
According to the etiology of ILD, pulmonary functions, will be assessed; FVC (ml) and (%pred)
Time frame: 1year
Pulmonary functions
According to the etiology of ILD, pulmonary functions, will be assessed; FEV 1 (ml) and (%pred)
Time frame: 1year
Pulmonary functions
According to the etiology of ILD, pulmonary functions, will be assessed; DLCO (mL.min.mmHg) and (%pred)
Time frame: 1year
Pulmonary functions
According to the etiology of ILD, pulmonary functions, will be assessed; DLCO/VA (mL.min.mmHg) and (%pred) 6dk YT (meters) Pulseoksimetre ile PaO2 (%)
Time frame: 1year
Pulmonary functions
According to the etiology of ILD, pulmonary functions, will be assessed; 6min Walk Test (meters)
Time frame: 1year
Pulmonary functions
According to the etiology of ILD, pulmonary functions, will be assessed; PaO2 with Pulse oximeter (%)
Time frame: 1year
Diagnostic methods
According to the etiology of ILD, diagnostic methods used in ILD cases will be presented Diagnoses methods are; Clinical and radiology, Bronchoscopic transbronchial lung biopsy, Bronchoalveolar lavage, Transthoracic needle biopsy with imaging, EBUS, VATS, Thoracotomy, Other (Methods are will be shown as YES or NO and %)
Time frame: 1year
Time
According to the etiology of ILD, the time spent for diagnosis will be presented Time will be presented as months.
Time frame: 1year
Treatment methods
Determining the treatment preferences of physicians according to the etiology of the cases will be presented; Treatment methods are; Non-treatment monitoring, Symptomatic treatment, Systemic corticosteroid, Cytostatic drugs, Antifibrosan drugs (eg Pirfenidone, Nintedanib), Immunological therapy, Referral to other centers, Preparing for transplantation, Home oxygen therapy, Reflux therapy, Other (Methods are will be shown as YES or NO and %)
Time frame: 1year